Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Aston Martin to limit laps in Australia with drivers at risk of nerve damage Aston Martin will limit their laps at the season-opening Australian Grand Prix to avoid the risk of their drivers suffering ...

The 2026 Formula 1 season starts at Melbourne Park with the Australian Grand Prix on the weekend of March 6-8. Lando Norris became world champion for the first time in 2025 after finishing third at a ...

Considered to be the pinnacle of motorsport, Formula One has amassed a huge global fanbase thanks to its enthralling mix of high-octane action and sporting drama. Merging cutting-edge technology with ...

Steven Nickolas is a writer and has 10+ years of experience working as a consultant to retail and institutional investors. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in ...

This calculation can be used for hypothesis testing in statistics Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive ...